Tremfya OverviewGuselkumab, sold under the trade name Tremfya, is a monoclonal antibody used to treat plaque psoriasis. Contents 1 Therapeutics 1.1 Medical uses 1.2 Adverse effects 2 Pharmacology 2.1 Mechanism of action 2.2 Pharmacokinetics 3 Commercialization 3.1 Cost 3.2 Manufacturer financials 3.3 Intellectual property 3.4 Research and development 4 See also 5 References Therapeutics Medical uses Guselkumab is FDA approved to treat moderate to severe plaque psoriasis in adults.[2...
Read more Tremfya Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Guselkumab
Recent Tremfya Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 100mg/ml
NDC Database Records for Tremfya: (1 result)Sorted by National Drug Code
- 57894-640 Tremfya 100 mg/ml Subcutaneous Injection by Janssen Biotech, Inc.